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Abstract
Background: Heterotrimeric G proteins are important for numerous signaling events in
eukaryotes, serving primarily to transduce signals that are initiated by G protein-coupled receptors.
It has recently become clear that nonreceptor activators can regulate the level of heterotrimeric
G protein signaling and, in some cases, drive cycles of receptor-independent G protein activation.
In this study, we used a yeast expression cloning strategy to identify novel nonreceptor activators
of heterotrimeric G proteins in a human adipocyte cDNA library.
Results: The human transcription factor E2F8 was found to activate heterotrimeric G proteins,
suggesting a specific biological role for this recently described member of the E2F family. Epistasis
studies showed that E2F8 acted at the level of G proteins and was specific for Gαi over Gpa1. E2F8
augmented receptor-driven signaling, but also activated G proteins in the absence of a receptor.
The GTPase-activating protein RGS4 antagonized the effect of E2F8, showing that E2F8's effect on
Gα involved nucleotide turnover. The entire E2F8 protein was required for full activity, but the
majority of the signaling activity appeared to reside in the first 200 residues.
Conclusion: In yeast, E2F8 is a guanine nucleotide exchange factor (GEF) for the α subunit of
heterotrimeric G proteins. The molecular mechanism and biological significance of this effect
remain to be determined.

Background
Cells use heterotrimeric G proteins to transduce a wide
variety of signals, including polypeptide hormones, small
molecules, odorants, and light. They are thus one of the
primary means by which cells gather information about
their environment [1]. In the conventional paradigm for
G protein signaling, a ligand-activated G protein-coupled
receptor (GPCR) is responsible for catalyzing the
exchange of GTP for GDP on the heterotrimer's α subunit.
This exchange results in the dissociation of the heterotrimer, releasing the α and βγ moieties to exert cell- and
context-dependent downstream effects. It has generally

been thought that activated receptors are the primary
source of guanine nucleotide exchange factor (GEF) activity for heterotrimeric G proteins. However, in recent years
it has become apparent that several nonreceptor GEFs also
exist, providing cells with a further level of control over G
protein activity.
One of the earliest nonreceptor GEFs to be identified was
GAP-43, also known as B-50 or neuromodulin. GAP-43 is
abundant in neuron growth cones and promotes axonal
pathfinding during development and regeneration [2].
Investigating the function of GAP-43, Fishman and cow-
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orkers found that it had GEF activity toward Gαo, another
protein that is abundant in growth cones, and that this
activity was synergistic with that of receptors [3-8].
More recently, a series of papers has described a diverse
collection of "activators of G protein signaling" (AGS proteins). AGS1 has intrinsic GEF activity [9,10], and the
mechanism of this activity appears to be analogous to the
GEF activity of receptors, since receptors and AGS1 can
compete for heterotrimers [11]. AGS2–8 activate G protein signaling in yeast, but appear to do so by disrupting
heterotrimers rather than by stimulating nucleotide
exchange on Gα [12].
The biological role of nonreceptor GEFs has been only
minimally elucidated, but a recent series of experiments
has defined a compelling function for one such molecule
in a specific developmental context. Ric-8A/synembryn is
a nonreceptor GEF with specificity for Go, Gi, and Gq [13].
C. elegans zygotes undergo an asymmetric first division
that requires Ric-8 for correct positioning of the mitotic
apparatus [14-16]. Ric-8 appears to be the GEF that drives
a receptor-independent cycle of GTP binding and hydrolysis, wherein each iteration of the cycle incrementally
repositions the mitotic spindle [17].
In the course of a screen for novel nonreceptor activators
of G proteins, we have found that human E2F8 promotes
nucleotide exchange on Gα subunits. This finding was
unexpected, since E2Fs have previously been considered
to be primarily transcription factors, modulators of apoptosis, and recruiters of chromatin remodeling complexes.
Here, we present evidence that the functions of E2F8
include augmentation of heterotrimeric G protein signaling, thus potentially linking two signaling pathways that
have heretofore been considered to be separate.

Results
E2F8 selectively activates Gαi in yeast
Identification of E2F8 by expression cloning
We screened a human adipocyte cDNA library to identify
novel activators of heterotrimeric G proteins. The screen
made use of an engineered S. cerevisiae strain (BY1142) in
which activation of the G protein/MAP kinase mating
pathway [18] resulted in transcription of the HIS3 gene,
allowing yeast to grow on medium lacking histidine (Figure 1) [19]. Plasmids conferring histidine prototrophy
were isolated from yeast colonies and sequenced; the phenotype was then confirmed by retransforming each plasmid into yeast and replica-plating on selective His- plates
containing 3-amino-1,2,4-triazole (3-AT). Since 3-AT is a
competitive inhibitor of the His3 gene product, the maximal tolerated concentration of 3-AT reflects the strength
of activation of the reporter.

http://www.jmolecularsignaling.com/content/2/1/3

The screen identified several cDNAs that would have been
expected to cause G protein or MAP kinase activation,
including three splicing variants of the lysophosphatidic
acid receptor [20] and a constitutively active MEKK2 [21],
thus validating our methodology. We also isolated three
identical clones encoding full-length E2F8 [22-24].
To confirm the signaling function of E2F8, we replicaplated yeast expressing E2F8, E2F8 fused to the yellow fluorescent protein (YFP), or empty vector onto selective
plates containing 0–100 mM 3-AT. E2F8- and E2F8-YFPexpressing yeast were able to grow on up to 100 mM 3-AT,
the highest concentration tested (Table 1), whereas the
empty vector control permitted only minimal growth of
yeast on 1 mM 3-AT. A constitutively active mutant of the
complement factor 5a receptor (C5aR NQ) was used as a
positive control; this receptor allowed growth on up to 10
mM 3-AT, as reported previously [25].
E2F8 activation of G protein signaling was verified by
using an episomal β-galactosidase reporter assay in place
of the yeast growth assay. We have previously described
reconstitution of signaling by the human complement
factor 5a receptor (C5aR) in yeast [25]. The receptor can
be activated by a small-molecule agonist, W5Cha, that is
able to cross the yeast cell wall. When E2F8 was expressed
in this system, the reporter was constitutively activated,
and this effect did not compete with the receptor-dependent signal (Figure 2). E2F8 had a small but statistically significant effect on the EC50 for receptor activation by
W5Cha, which was 150 nM in the absence of E2F8 (95%
CI, 120–170 nM) and 59 nM in the presence of E2F8
(95% CI, 52–67 nM). These results show that E2F8 is a
receptor-independent means of activating G proteins, but
is also able to augment receptor-mediated signaling.
Epistasis mapping of E2F8 function
The signaling activity of E2F8 could in theory arise from
activation at any level of the G protein/MAP kinase
reporter cascade (Figure 1), including transcriptional
upregulation of cascade components. To map E2F8's site
of action, we tested it for signaling in yeast strains that
were deficient for specific components of the cascade
(Table 2). We found that E2F8 was downstream from
receptors, since it signaled in yeast BY1142, which lacks
the endogenous Ste3 gene (a-mating factor receptor). On
the other hand, E2F8 was upstream of Ste4Gβ,
Ste11MAPKKK, and Ste12 (MAP kinase substrate). In yeast
lacking any of these components, E2F8 failed to activate
transcription of the HIS3 reporter. It therefore appeared
that E2F8 activated the G protein/MAP kinase cascade at a
point no lower than G proteins. These screens were performed in the absence of any receptor, so E2F8 must
either act directly on G proteins or act to increase the cellular level of free Gβγ.
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FigureG 1protein/MAP kinase reporter cascade
Yeast
Yeast G protein/MAP kinase reporter cascade. In S. cerevisiae strains BY1142 and BY1173, activation of an episomally
expressed mammalian GPCR stimulates nucleotide exchange on a chimeric Gα subunit. The newly free βγ moiety activates a
MAP kinase cascade that leads to transcription of the HIS3 reporter gene, allowing growth on histidine-deficient medium.
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Table 1: G protein activation by E2F8

ADE2 plasmid
E2F8
E2F8-YFP
C5aR NQ
Vector
Yeast BY1142, which expresses a chimeric

Signaling

Fluorescence

+++++++
+++++++
++++
-

+
-

Gαi3,Gpa11− 41 subunit, was transformed with the indicated ADE2 plasmids along with empty URA3

vector. Transformants were replica-plated onto Ura- His- Ade1 mM plates containing varying concentrations of 3-AT. Yeast were assessed for growth
after 3 days. The maximal concentration of 3-AT tolerated by the transformants is indicated: 100 mM (+++++++), 50 mM (++++++), 20 mM
(+++++), 10 mM (++++), 5 mM (+++), 2 mM (++), 1 mM (+), or 0 mM (-). Fluorescence was determined by examining yeast colonies on a
dissecting microscope and is reported as either + (fluorescent colony) or – (non-fluorescent colony). C5aR NQ, a constitutively active mutant of
the C5a receptor, was used as a positive control.

Alternatively, the activity of E2F8 may require a small
amount of upstream basal activity, which it can then
amplify at a downstream point. The G protein specificity
of E2F8 (described below) argues against this possibility.
G protein specificity of E2F8
To further characterize the site of action of E2F8, we reasoned that if E2F8 interacted directly with Gα, it might
show selectivity for particular Gα isoforms. To test this
hypothesis in the yeast system, we measured signaling by
E2F8 in yeast strains expressing different Gα subunits.

All of the yeast strains used in our studies contained yeast/
human chimeric Gα subunits. Wild-type mammalian G
proteins do not signal when expressed in yeast because
they cannot couple to downstream components of the
yeast G protein/MAP kinase cascade. Chimeric Gα subunits have the advantage that they can be activated by
mammalian receptors, but can also interact with yeast
Gβγ[25,26].
Strain BY1142 contains a Gα subunit consisting of 41 residues of the endogenous yeast Gα (Gpa1) followed by residues 32–354 of human Gαi3 (yielding the chimera
Gαi3,Gpa1(1–41)). In this strain, E2F8 strongly activated the
MAP kinase cascade (Table 2).
BY1173 contains instead an α subunit (Gpa1DCGLF) identical to Gpa1 except for its last five residues, which are
derived from human Gαi. The chimerism of Gpa1DCGLF
allows it to interact with Gαi-coupled receptors, but in the
absence of a receptor this G protein is functionally identical to Gpa1. E2F8 showed no activity when expressed in
BY1173 (Table 2), indicating that it was selective for Gαi3
over Gpa1. These findings do not necessarily define the
endogenous G protein coupling of E2F8, but rather indicate that E2F8 is specific for particular Gα isoforms and
must therefore act at the level of Gα.

RGS4 inhibition of E2F8 signaling
We wished to determine whether E2F8 catalyzed nucleotide exchange on Gα or, instead, served to disrupt Gαβγ
heterotrimers, for example by binding to Gα-GDP and
sequestering the Gα subunit away from Gβγ. Either of
these mechanisms would increase free Gβγ, which is
responsible for signaling in the yeast mating cascade. To
differentiate between these two possibilities, we determined whether E2F8's effect was antagonized by coexpression of RGS4. The GTPase-activating protein RGS4
catalyzes nucleotide hydrolysis on Gαi-GTP [27], thus
inactivating the protein and promoting re-association of
heterotrimers. If E2F8 served merely to displace Gβγ, then
its effect would be indifferent to the nucleotide binding
state (GTP or GDP) of Gα.

In yeast BY1142, E2F8 alone allowed yeast to grow on up
to 100 mM 3-AT, but when RGS4 was co-expressed, the
signaling was reduced to 1 mM (Table 3). Thus, G protein
activation by E2F8 requires nucleotide cycling on Gα. As
a control, we verified that the signaling activity of a constitutively active GPCR (C5aR NQ [28]) was antagonized
by fluorescently tagged RGS4, consistent with the receptor's ability to catalyze nucleotide binding on Gαi. The
simplest interpretation of these data is that E2F8 increases
free Gβγ by promoting GTP-for-GDP exchange on Gα. It
seems unlikely that E2F8 merely stabilizes the GTP-bound
state, as it can activate G proteins in the absence of receptors or any other guanine nucleotide exchange factor
(GEF).
Structure/function analysis of E2F8
E2F8's ability to activate G proteins was highly surprising,
as this would be a novel function for a member of the E2F
family. We examined the sequence of E2F8 to identify any
motifs that might shed light on the behavior we observed.
The primary structure of E2F8 contained two E2F DNAbinding domain at positions 112–182 and 260–357; each
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Table 2: Epistasis mapping and G protein specificity of E2F8 signaling

Yeast strain

Gα subunit

Reporter cascade mutations

ADE2 plasmid

BY1142

Gαi3,Gpa1(1–41)

Intact reporter cascade

BY1187

Gαi3,Gpa1(1–41)

ΔSte4Gβ

BY1206

Gαi3,Gpa1(1–41)

ΔSte11MAPKKK

BY1207

Gαi3,Gpa1(1–41)

ΔSte12 (MAPK substrate)

BY1173

Gpa1DCGLF

Intact reporter cascade

E2F8
Vector
E2F8
Vector
E2F8
Vector
E2F8
Vector
C5aR NQ
E2F8
Vector

Signaling
+++++++
++++
-

A plasmid encoding E2F8 or empty vector (ADE2 selection) and empty URA3 vector were transformed into the indicated yeast strains.
Transformants were replicated onto selective plates containing 3-AT and assessed for growth after 3 days. The strength of signaling is reported as
in Table 1.

of these regions included the canonical RRXYD motif that
interacts directly with DNA [29] (Figure 3). The remaining
regions of E2F8 exhibited only minimal similarity to
other known proteins, as determined by BLAST searching
[30].
In light of E2F8's surprising ability to activate G proteins,
we asked whether it was similar to other known proteins
with this function. E2F8 lacks the G protein regulatory
(GPR) sequence that appears to define the Gα-GDP-stabilizing AGS proteins [31]. Intriguingly, we found that E2F8
did contain an extended region of homology to GAP-43,
a known nonreceptor GEF: between residues 400 and 630,
E2F8 was 27% similar to GAP-43 and 16% identical. On
the other hand, the homology domain did not include the
first ten amino acids of GAP-43. These residues of GAP-43
are sufficient to activate Go, albeit with low potency [7].
We constructed a series of E2F8 truncation and deletion
mutants to identify regions of the protein that were
required for function. The mutants were fused to YFP to
allow expression to be verified. Truncation of the first 200
amino acids of E2F8 eliminated its ability to activate G
proteins (Figure 4A), suggesting that the N-terminal
domain was required for the activity. Consistent with this
hypothesis, E2F8 residues 1–401 were sufficient to activate the reporter pathway, although they did so less
strongly than the full-length protein. Interestingly, the
E2F8 (1–602)-YFP construct was not able to activate G
proteins. The truncation may in this case have resulted in
misfolding, or residues 402–602 may have autoinhibitory
functions. Two E2F8 constructs in which the GAP-43
homology domain was completely (E2F8 Δ(399–630)YFP) or partially (E2F8 Δ(399–500)-YFP) deleted did
retain signaling ability, suggesting that the ability to activate G proteins did not reside in this domain. Since none
of the mutants had full activity, it appeared that the entire

protein was required for wild-type signaling in this system, but that the majority of the activity resided in the Nterminal region.
The variable signaling by E2F8 mutants did not simply
reflect failure of some mutants to be expressed in yeast. All
of the YFP-tagged mutants resulted in yeast fluorescence,
arguing that the proteins were expressed (Figure 4A). Most
of the mutants could be detected by immunoblotting, but
their apparent levels were quite variable, reflecting either
variable expression, degradation of the proteins during
yeast lysis, or insufficient sensitivity of our technique (Figure 4B). There was, however, no correlation between
strength of signaling and detection of the protein by
immunoblot. E2F8-YFP, which signaled strongly, was
only faintly detected, whereas E2F8 (1–602)-YFP, which
did not signal, was strongly detected.
Importantly, all of the constructs that failed to signal were
detected at least weakly by immunoblot, showing that
they were expressed-particularly since these contructs also
rendered yeast fluorescent. We cannot, however, exclude
the possibility that different expression levels contributed
somewhat to the different phenotypes we observed with
the mutants.

Discussion
We identified the transcription factor E2F8 in the course
of a screen for novel activators of heterotrimeric G proteins. In S. cerevisiae, E2F8 was able to activate a G protein/
MAP kinase reporter pathway; this activity was specific for
particular G protein isoforms, mapped epistatically to the
level of heterotrimers, and was antagonized by a GTPaseaccelerating protein. The amino-terminus of the protein
appeared to be most important for G protein activation.
The most parsimonious interpretation of these results is
that E2F8 stimulates nucleotide exchange on the α subu-
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pRb; the E2F moiety is released to serve as a transcription
factor when pRb is phosphorylated by cyclin/Cdk complexes. E2F4 and 5 also bind to pocket proteins (pRb,
p107, and p130) but act primarily to repress E2F target
genes by occupying promoters and remodeling chromatin, allowing cells to maintain G0 arrest. E2F6 lacks the
transactivation-related and pocket protein-binding
domains of E2F1–5, but appears to have functions similar
to the other repressive E2Fs [32,34]. E2F1–6 all bind to
DNA most efficiently as an E2F/DP heterodimer [35].

E2F8/C5aR
vec/C5aR
E2F8/vec
vec/vec

2.0
1.5
1.0
0.5
0.0
-10

-9

-8

-7

-6

-5

log [W5Cha] (M)
Figure
E2F8
effect
2 on receptor-mediated signaling
E2F8 effect on receptor-mediated signaling. Yeast
BY1142 was transformed with a PFUS1-LacZ reporter construct (TRP1 selection), then transformed with plasmids
encoding E2F8 or empty vector (ADE2 selection) and C5aR
or empty vector (URA3 selection). The agonist W5Cha was
used to activate the receptor. After four hours of ligand
treatment, cells were lysed and β-galactosidase activity was
measured by colorimetry. This experiment is representative
of three independent trials, each of which examined three
transformants per condition.

nit of heterotrimeric G proteins. Since E2F8 did not
reduce the maximal receptor-mediated signal (Figure 2),
but rather caused a left-shift in the receptor's doseresponse curve, E2F8 does not compete with receptors for
G proteins. Instead, E2F8 and receptors may be complementary to one another in their mode of action, using different molecular mechanisms to activate Gα.
G protein activation would be a novel function for an E2F
transcription factor. The E2F family of transcription factors has classically been associated with cell-cycle regulation and cell differentiation [32,33]. The "activating"
subgroup, E2F1–3, consists of proteins that are bound by

E2F8's apparent ability to activate G proteins may account
for its having arisen over the course of evolution.
Although both E2F7 and E2F8 have been shown to repress
a subset of E2F-regulated genes and reduce cell proliferation, no special function has yet been shown for them. It
may be significant that the newer E2Fs are structurally dissimilar to the previously described and well-characterized
E2F1–6; unlike these, both E2F8 and E2F7 lack a DP
dimerization domain and can bind to DNA efficiently in
the absence of DP [22-24,36-38]. In this respect they are
similar to the Arabidopsis proteins E2L1–3 [39].
Furthermore, they lack a pocket protein interaction
domain and therefore are unlikely to interact with pRb,
p107, or p130. In yeast, we found that murine E2F7 did
not activate G proteins, but we were unable to verify that
the protein was expressed (data not shown).
It is curious, but not inconceivable, that a transcription
factor should also activate heterotrimeric G proteins. Cellsurface receptors are the primary means by which cells
acquire information about their hormonal environment,
and these hormonal cues frequently trigger signaling cascades that culminate in a transcriptional response. Many
of these cascades use heterotrimeric G proteins as a signaling intermediate, and integrating G protein regulation
with transcriptional activity may be important for the
coordination of complex cellular processes. For example,
the Tubby protein, whose loss causes obesity and retinal
degeneration in mice [40], is both a transcriptional regulator and an effector of Gq signaling.

Table 3: Effect of RGS4 on E2F8 signaling

ADE2 plasmid

URA3 plasmid

C5aR NQ

Vector
RGS4-GFP
Vector
RGS4-GFP
Vector
RGS4-GFP

E2F8
Vector

Signaling

Fluorescence

++++
+
+++++++
+
-

+
+
+

Yeast BY1142 was transformed with the indicated plasmids. Three transformants per condition were replicated onto selective plates containing 3AT and assessed for growth after 3 days. The strength of signaling and fluorescence is reported as in Table 1.
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Figure 3structure of E2F8
Domain
Domain structure of E2F8. E2F8 includes two E2F homology domains, both of which contain the RRXYD consensus motif
that interacts directly with DNA. The region 400–630 has 16% amino acid identity with GAP-43, a known activator of heterotrimeric G proteins. Approximate boundaries of the homology regions are indicated. The percentage of amino acid identity to
human E2F1 and E2F7 is indicated for the regions 1–200 and 610–867.

As one possible model of E2F8 function, it could be the
case that E2F8 serves to set a basal level of G protein activity that is then modulated by receptor activity. The level of
E2F8 activity on G proteins could itself be controlled by
redistributing E2F8 between the nucleus and cytosol.
Since E2F8 has three nuclear localization sequences
(NLSes) [22] and has transcriptional effects, it presumably
is localized to the nucleus at some times, but it must also
at times be located in other compartments if it is to have
effects on heterotrimeric G proteins. It is also possible, in
a second model, that E2F8 participates in a receptordependent G protein activation event, although receptors
were not necessary for E2F8 activity in the yeast system.
E2F8 could facilitate receptor-stimulated G protein activation, then undergo relocalization to the nucleus to exert
transcriptional effects. Thus E2F8 would be both the agent
and the object of a signaling event, and a cell-surface
receptor could have a relatively direct influence on the
transcription of E2F-responsive genes. We do not yet have
sufficient data to conclusively test these models.

icity data presented here would, however, seem to rule out
a direct transcriptional role of E2F8 in yeast (such as E2F8
upregulation of Gβ). Furthermore, a human E2F protein
(E2F1) was previously found to be unable to bind to S.
cerevisiae genomic DNA [41], again arguing against transcriptional effects.

It is not known whether the observed activity of E2F8 is
physiologically significant in mammalian cells, as
opposed to the heterologous yeast system. The yeast
growth assay has been described numerous times in the
literature, including in previous studies of nonreceptor G
protein activators such as the AGS proteins [9]. However,
we cannot exclude the possibility that the E2F8/G protein
interaction may reflect some unexpected feature of the
yeast system. The yeast G protein cascade differs from the
canonical mammalian cascade in that free Gβγ is the
active signaling moiety. The epistasis and G protein specif-

Finally, the influence of E2F8 on G proteins was identified
in yeast, but this interaction must next be studied in a
more physiologically relevant system. One obstacle to
studies in mammalian tissue culture is that E2F8 appears
to cause cell-cycle arrest when overexpressed [22-24].
Likewise, in our efforts to make stably transfected mammalian cell lines, E2F8 was lost within a few passages
(data not shown). An inducible expression system could
be a useful workaround, but it would be equally valuable
to investigate the role of E2F8 in a system where it natively
plays a demonstrable biological role. Given that E2F8 was

Numerous future experiments are needed to more fully
characterize the role of E2F8 in G protein activation and
cellular signaling. The present data are essentially genetic
in nature and would be strengthened by complementary
biochemical evidence. In vitro studies with purified E2F8
and G protein subunits would allow the hypothesis of a
direct effect to be tested and would allow G protein specificity to be more thoroughly determined. G protein-E2F8
binding studies would also show more conclusively
whether a physical interaction can occur. Further effort
should be devoted to determining whether E2F7 or the
plant E2Fs also interact with G proteins, as this activity
may not be limited to E2F8.
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Figure 4
Structure/function
analysis of E2F8
Structure/function analysis of E2F8. (A) Yeast BY1142 was transformed with the indicated E2F8 mutants (ADE2 selection)
along with empty URA3 vector. Transformants were replicated onto selective plates containing 3-AT and assessed for growth
after 3 days. The strength of signaling and fluorescence is reported as in Table 1. (B) Yeast cells expressing E2F8 mutants were
grown in liquid culture, lysed, and examined by immunoblotting using an anti-GFP (top) antibody. The membrane was stripped
and reprobed using an anti-β-actin antibody (bottom) as a loading control. The 5' UTR-E2F8-YFP construct contained the wildtype 5' UTR in addition to E2F8; the other full-length construct lacked the UTR.

Page 8 of 11
(page number not for citation purposes)

Journal of Molecular Signaling 2007, 2:3

cloned from a mature human adipocyte cDNA library,
adipose tissue appears to be an interesting starting point
for this effort.

Conclusion
In yeast, E2F8 served as a strong activator of nucleotide
exchange on the Gα subunit of heterotrimeric G proteins.
The effect was inhibited by coexpression of RGS4,
appeared to occur directly at the level of G proteins, and
was primarily derived from residues 1–200 of E2F8.
Future studies are needed to determine whether this effect
is important in vivo and to delineate its molecular mechanism.

Methods
Yeast strains
Yeast strain BY1142 has genotype MATα far1Δ1442 tbt1-1
PFUS1-HIS3 ste14::trp1::LYS2 ste3Δ1156 Gαi3,Gpa1(1–41) his3
leu2 lys2 trp1 ura3 can1 ade2. Yeast BY1173 has genotype
MATa his3 leu2 trp1 ura3 can1 gpa1::ade2::3 × HA
far1::ura3 fus1::PFUS1-HIS3 LEU2::PFUS1-lacZ sst2::ura3
ste2::G418R trp1::GPA1DCGLF. Yeast strains with deletions
of STE4 (BY1187), STE11 (BY1206), or STE12 (BY1207)
were derived from BY1142 by gene replacement in our
laboratory. Yeast were transformed by the lithium acetate
procedure or by electroporation and were grown on selective media at 30°C. Fluorescence of yeast colonies was
determined by examining them at 500× magnification on
an Olympus SZX12 dissecting microscope with a mercuryarc light source (Hitschfel Instruments) and YFP or GFP
filter set (Olympus).
Plasmids and cloning
The human adipocyte library (gift of Robin Weinberg,
Pharmacia Corp..) consisted of mature human adipocyte
cDNA cloned into vector pBN975 under the ADH promoter with ADE2 selection. The library consisted of
approximately 3 × 106 clones. When 24 unselected clones
were analyzed, 22 contained an inserted cDNA, with average insert size 1200 bp; the inserts ranged in size from 500
bp to 3000 bp. The plasmid encoding RGS4 fused to the
green fluorescent protein (GFP) was a gift of Maurine
Linder (Department of Cell Biology and Physiology,
Washington University). The constitutively active NQ
mutant of the C5a receptor has been described previously
[25].

The E2F8-YFP plasmid was constructed by homologous
recombination in yeast. The polymerase chain reaction
(PCR) was used to construct a DNA fragment containing
the sequence of YFP with a 5' arm of homology to E2F8
and a 3' arm of homology to the library vector. These
inserts were transformed into yeast BY1142 along with a
double-cut parent vector in a 1:1 molar ratio. Constructs
were isolated from yeast by plasmid rescue and verified by
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sequencing (Protein and Nucleic Acid Chemistry Laboratory, Washington University School of Medicine).
E2F8 mutants were also constructed by homologous
recombination in yeast. In all cases, an E2F8 insert with 5'
ADH promoter homology and 3' YFP homology was
recombined into a double-cut YFP vector. For the truncations, PCR was used to synthesize inserts containing the
desired E2F8. Recombination was performed as described
above. The deletion mutants were constructed by a twostep PCR strategy. In the first step, PCR products encoding
E2F8 (1–398) and E2F8 (630–867), or E2F8 (1–398) and
E2F8 (501–867), were amplified with arms of homology
to the vector and to each other. In the second step, these
products were used as templates for an overlap extension
PCR reaction. The full-length PCR products were then
used for homologous recombination as described above.
Library screening
The human adipocyte library was screened by the yeast
growth assay (described below) to identify cDNAs that
activated the G protein/MAP kinase mating cascade. A
total of 1.7 × 106 transformants were screened. cDNAs
conferring growth were isolated by plasmid rescue and
retransformed into yeast to reconfirm the phenotype.
Confirmed positives were then sequenced.
G protein signaling assays in yeast
For the growth assay, selected yeast colonies were streaked
onto a master plate (Ura- Ade-), then replica-plated onto
selective plates (Ura- His- Ade1 mM) containing increasing
concentrations of 3-AT (Sigma). The minimal concentration of adenine in the selective plates allowed us to use
color selection to ensure that signaling was plasmiddependent: if a reporter pathway mutation arose — allowing plasmid-independent growth — and the ADE2 plasmid was lost, yeast still grew on minimal adenine
medium, but developed a red color that allowed those
colonies to be excluded from consideration [42].

For β-galactosidase assays, yeast were grown in liquid culture and seeded into microtiter plates (Costar) at an
OD600 of 0.015 units/cm. The small molecule W5Cha [43]
was used as an agonist. After a four-hour incubation at
30°C in the presence of ligand, a lysis/substrate buffer was
added (final composition 0.5% Triton X-100, 1 mg/ml
chlorophenol red β-D-galactopyranoside, 25 mM PIPES,
pH 6.8) and color development was allowed to proceed
for fifteen hours, then was stopped by addition of Na2CO3
to 0.2 M. Color was assessed by measuring OD570 on a BioRad plate reader, model 680.
Immunoblotting
For yeast studies, yeast were grown overnight in selective
media to an OD600 of 1.5 units/cm. Cells were harvested
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from 1 ml of culture and lysed by vortexing at room temperature for 5 min with 100 μl of acid-washed beads (0.5
mm diameter) and 150 μl of 1× SDS sample buffer containing PMSF (100 μg/ml) and aprotinin, leupeptin, and
pepstatin (all 1 μg/ml). A 1 min centrifugation step (1000
× g) was used to clarify the lysate, and the supernatant was
used for immunoblotting.
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9.

10.

11.

For immunoblots, proteins were separated on SDS-PAGE
and transferred to PVDF using a wet transfer apparatus
(Bio-Rad). Membranes were blocked with 5% milk in
phosphate-buffered saline with 0.1% Tween-20 for 1
hour, then probed with primary and secondary antibodies. Rabbit anti-GFP antibody (Santa Cruz) was used at
1:200 dilution and mouse anti-β-actin (ab8224, Abcam)
at 1:800. Secondary antibodies were goat anti-rabbit or
goat anti-mouse horseradish peroxidase conjugates (Santa
Cruz) at 1:10,000 dilution. A chemiluminescent substrate
(Lumi-Light Plus, Roche) was applied for five minutes,
and signal was recorded using a FluorChem 8900 detection system (Alpha Innotech Corp.).
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